{"name":"Partner Therapeutics, Inc.","slug":"partner-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwJBVV95cUxOYThaQjFCMTRTdzBDc2ZxYTcyNGtjdEw2MnRFMHNnMVNDUEV6LVRCdFA2b1Nqd196YWJIeGc1SW5TUVBxWFBaYlRCWFREQjQxSVktXzZNTVFtSVVEQnFKTU9vcDIwd2kyVW50LUtxNjhoWlIyZlFxUWJLT3pkbWhub3BFVkx3aVJNanJDQjNXbFgzY1labmc3UUNUX3N2T2hwbE5NaVdvenFLSmxqRFFjb3h3T1BJeWpzeW4tZmFZQmNYUk4zRm54SXVqUFJkd0dBZXdET1ZWWWVhbnFzZHM0MTlvaExid0tCVDFORXhKUUZkczFDVkFqQ0hacFR3Sm0ybXpGVnJpamlSUDZUcHB3S2dXMW5MdUdvdVltRWpQb09sZXJOYUZxci1FRW5LQXc?oc=5","date":"2026-02-09","type":"pipeline","source":"globenewswire.com","summary":"Verrica Pharmaceuticals Announces Launch of YCANTH® for the - globenewswire.com","headline":"Verrica Pharmaceuticals Announces Launch of YCANTH® for the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxPUktQcEl6ZVQ5ZGhTdnhhdi1BSXQwUU1QS1BpclU2ZnBxbUllX2NzSTkyejZzUFpaTHc4YWc0SjBJV0M2ZnZGaEFqZUxXU3BoU2k5U010bUl6R09uYWdsRzVtUzd6ekNOa0w4SXQ2SGFnT2ZsWnU4emc5S3VDOTFvVkNFSzd4NXRJbExHbWJ3ZFRQWC15U2VGeVZ4UF9RamVNTDA3UjF1djJsLVhvT3pnQ2E4dkVSZ01ETWs0NmMyN016UWdPQUwtWUk3aG9IQzViZTctZUNmSXU5M0JxbVo0?oc=5","date":"2026-02-05","type":"regulatory","source":"PR Newswire","summary":"Zenocutuzumab‑zbco Receives FDA Orphan Drug Designation for Treatment of Cholangiocarcinoma - PR Newswire","headline":"Zenocutuzumab‑zbco Receives FDA Orphan Drug Designation for Treatment of Cholangiocarcinoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPU3pvVWFDd0ZfazJEODF5YVoyWG1QTXkycFVSblVFdFRaS2RNa3JLMHFaV3JTWFhjMDZ6UEttZFk4TW1pLUxIUlBtTDNrMW9odE9wQWxMbHlsQWVDaGJMeDJNTkJ3WW82Qy1JVWcyNFRYRzB3RFlTQTgwOTQ3UHM3allGNHRVZDFYQTdXcUJmcw?oc=5","date":"2026-01-14","type":"deal","source":"Yahoo Finance","summary":"Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP) partner to address multi-billion dollar anti-infective and oncology therapeutics market - Yahoo Finance","headline":"Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP) partner to address multi-billion dollar anti-infective and onc","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-23","type":"regulatory","source":"PR Newswire","summary":"Zenocutuzumab-zbco Granted FDA Breakthrough Therapy Designation for NRG1+ Cholangiocarcinoma; Data Highlighting Potential of Zenocutuzumab-zbco in NRG1+ Cholangiocarcinoma to be Presented at AACR-NCI-","headline":"Zenocutuzumab-zbco Granted FDA Breakthrough Therapy Designation for NRG1+ Cholangiocarcinoma; Data Highlighting Potentia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxPM2ZTTHRYN201bjNKNkptLUtOSmpmV2o1ZlczcE91LW5FSktjTTJmNFZWVmU1YlRWREZweHE2Z0xhREtObjZrZl82VWtPTmJRMnB4aUhSTU1Ya2s4Mjg5Unh3RjV4NG53VWhjYVNaZkRHYWRhcmYteHF6blRtV0NBWmRjcHh0Q2ZBUGcyTjlRR1JUYkVyaVNmaTZIMmlVUHFzbGVIWTNxNjJnNTZkZVZfcnFwZU0xYmlBeDgwTFN4Ml9ScGdQd3lvWTQ0TEtrd181YW9Tc2hnajYtSHJfSHRKX3paTXlIMGNX?oc=5","date":"2025-09-17","type":"deal","source":"Wilson Sonsini","summary":"Firm Advises Centerview Partners as Financial Advisor to Y-mAbs Therapeutics in Acquisition by SERB Pharmaceuticals - Wilson Sonsini","headline":"Firm Advises Centerview Partners as Financial Advisor to Y-mAbs Therapeutics in Acquisition by SERB Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-09","type":"regulatory","source":"PR Newswire","summary":"Partner Therapeutics Receives EMA Approval of IMREPLYS® (sargramostim, rhu GM-CSF) to Treat Exposure to Myelosuppressive Doses of Radiation (Hematopoietic Sub-syndrome of Acute Radiation Syndrome [H-A","headline":"Partner Therapeutics Receives EMA Approval of IMREPLYS® (sargramostim, rhu GM-CSF) to Treat Exposure to Myelosuppressive","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOeFItZVNnREJvRHF0ak5nUmhPcTNFaUN6RDRZQTRSS3plaHI0eWI0b0xOVHJRckRPVmJqbnlOaXBNV25PNnZJdEZMcUZoOGREOVBnYXlIMl9ZUFRwWkpCSlFZUmIwWG14VVBSZmxYYkFLZm5zTDIzcHR3NVlGZXFQR3JHTVRndURQd1RzWTVHeDA3QTVjUUFFTW1RcFZBQmVD?oc=5","date":"2025-06-24","type":"deal","source":"Contract Pharma","summary":"Starton Therapeutics, Bend Partner to Advance STAR-LLD - Contract Pharma","headline":"Starton Therapeutics, Bend Partner to Advance STAR-LLD","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-06-20","type":"regulatory","source":"PR Newswire","summary":"European Medicines Agency CHMP Recommends EU Approval of Partner Therapeutics IMREPLYS® (sargramostim, rhu GM-CSF) to Treat Exposure to Myelosuppressive Doses of Radiation (Haematopoietic Sub-syndrome","headline":"European Medicines Agency CHMP Recommends EU Approval of Partner Therapeutics IMREPLYS® (sargramostim, rhu GM-CSF) to Tr","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPbjN4Q1p0eE9wMXNySm5peENIaUxYSzZ3MThHUk1DRmlCMS1hQjFIM0JJSlMyQmZzTlEwRGp3Y1ZXWS1CZzBPTHo0U1BidDV5RGpYT2kySGZkQ2t1SGFnRnhTQTlreExMLTFSS1B5T1pnbF9ZREhUYVJyZm81dDJrNGtjUGpaalJwcnZlUS1EQmpKakRFRkRzOTlmeWVLbFpxRmpkR3d0STZhcmRZQTFkQkZTQzVONHhfRnRCV0JtUWpMYWdKYVV1OUVhYl9UR2F0anFmOUUxZzdPOXo0a2o3eFJSUmxVVkFwOTIxVEdTV2pKYzFHRFhUaFZURmJQM0NPaTExRWdob2U?oc=5","date":"2025-05-16","type":"deal","source":"Monumental Sports","summary":"Monumental Sports & Entertainment Announces Vanda Pharmaceuticals Inc. as Official Partner and Jersey Patch Partner for the Washington Mystics - Monumental Sports","headline":"Monumental Sports & Entertainment Announces Vanda Pharmaceuticals Inc. as Official Partner and Jersey Patch Partner for ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgJBVV95cUxOTUYtQnlwbVFfX0R2WDBPTndqaHFQeTJsd3VmY1A1VTQ4cnRmLWY0RXZObGlKS1lIYXFJR1FXZmtXZi14RlR6VmRaaFljdmYzcVgyQ1F0S3Q3dGtuc3ZfSHBXUGlFS0pZM1FBbFpuWWJVQy1jdjZud1Y2TVdtNTczVi1YUWdkRHN3S0wyVi11TUVMcXNOX1FiQkZqUnNxVW9oODctb3BHd0xLSVZ1bV9tblBjSGVxU2R4cmE0bThFbHhmVXQzUlhIemZRTEt0NTN2ckVRcEo4U0VLWl9yV1AwN0R0Yk1ya1ZmU0ZiTlIwYWVubGd5eWZDQ1owc3FBMnRCZDk3cWd3UUpHaVpBMlVqVldyQXBYbkx4TTEzY1hwUDVZdWVVNGxKZVNSSzRJYVAwVjNuVDN3?oc=5","date":"2024-12-02","type":"deal","source":"globenewswire.com","summary":"Merus and Partner Therapeutics Announce License Agreement - globenewswire.com","headline":"Merus and Partner Therapeutics Announce License Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOYkdzdWd2TVF3d0daaUtCSl9NQWVKM3VlLTNFTW5IbnJQcENnQUpEY2RXZEY2ZWJ3dmlTOHpoc1M2cGw2eWJ3TS1GbkRxSEpMVXg2cmJWeWNpV1E5c3R2enBaTldkam5sQ0xRMFpBcEZpMzNudUxPM083VTRDUEY5VjNSeWM4UGJwUkVvbnMxR1R5LXZLOU5iYUFjN3AxUDVFMnNmM2RoX0M?oc=5","date":"2018-03-22","type":"deal","source":"Fierce Pharma","summary":"PTx will hire 40 for U.S. Leukine plant it acquired from Sanofi - Fierce Pharma","headline":"PTx will hire 40 for U.S. Leukine plant it acquired from Sanofi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNRFZQNXBJWGVWNnZJaWFtOXBtdUFZS2d6MEg5LU51NHFvRHNYdTV2OUgxRXdOMzZWTXlhRlF4bnBjNk1ZZm1mVzRNX2NaTTFsNE5FQ0xCTUotWUhhTVBtTDllc2hJeUtuSDVVSTE1MnFkNmc0dmN1c0syTW9GaWltSU9mUFNaNjVIcVRGY3NydEpkSlZyNnE3a0t1MA?oc=5","date":"2018-02-06","type":"deal","source":"Contract Pharma","summary":"Partner Therapeutics Acquires Leukine from Sanofi - Contract Pharma","headline":"Partner Therapeutics Acquires Leukine from Sanofi","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}